TAYSHA GENE THERAPIES INC

Ticker: TSHA CUSIP: 877619106 Class: Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,854,855 Value ($000) $10,202 Avg Close $4.86 Range $3.10 - $6.02
Q3 2025
Shares 367,309 Value ($000) $1,201 Avg Close $2.83 Range $2.25 - $3.40
Q2 2025
Shares 528,993 Value ($000) $1,222 Avg Close $2.17 Range $1.05 - $3.24
Q1 2025
Shares 216,611 Value ($000) $301 Avg Close $1.67 Range $1.17 - $2.07
Q4 2024
Shares 745,205 Value ($000) $1,289 Avg Close $2.07 Range $1.19 - $3.31
Q3 2024
Shares 2,859,972 Value ($000) $5,749 Avg Close $2.19 Range $1.93 - $2.53
Q2 2024
Shares 46,854 Value ($000) $105 Avg Close $2.91 Range $1.83 - $4.32
Q1 2024
Shares 197 Value ($000) $1 Avg Close $2.08 Range $1.38 - $3.55
Q4 2023
Shares 2,297,556 Value ($000) $4,067 Avg Close $1.99 Range $1.27 - $3.19
Q2 2023
Shares 11,293 Value ($000) $7 Avg Close $0.72 Range $0.50 - $0.96
Q1 2023
Shares 11,293 Value ($000) $9 Avg Close $1.29 Range $0.61 - $2.41
Q4 2022
Shares 183,711 Value ($000) $415 Avg Close $2.02 Range $1.35 - $3.00
Q3 2022
Shares 50,580 Value ($000) $97 Avg Close $3.63 Range $1.68 - $5.09
Q2 2022
Shares 110,591 Value ($000) $411 Avg Close $3.97 Range $2.33 - $7.07
Q1 2022
Shares 208,749 Value ($000) $1,361 Avg Close $7.48 Range $5.00 - $12.17
Q4 2021
Shares 36,337 Value ($000) $423 Avg Close $15.08 Range $11.12 - $19.54
Q4 2020
Shares 35,752 Value ($000) $949 Avg Close $21.54 Range $18.16 - $29.96
Q3 2020
Shares 245,034 Value ($000) $5,489 Avg Close $23.52 Range $20.50 - $27.53